| Ligand binding mechanism in steroid receptors: from conserved plasticity to differential evolutionary constraints K Edman, A Hosseini, MK Bjursell, A Aagaard, L Wissler, A Gunnarsson, ... Structure 23 (12), 2280-2290, 2015 | 109 | 2015 |
| Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: prodigiosin vs. obatoclax M Espona-Fiedler, V Soto-Cerrato, A Hosseini, JM Lizcano, V Guallar, ... Biochemical pharmacology 83 (4), 489-496, 2012 | 85 | 2012 |
| Molecular interactions of prodiginines with the BH3 domain of anti-apoptotic Bcl-2 family members A Hosseini, M Espona-Fiedler, V Soto-Cerrato, R Quesada, ... PloS one 8 (2), e57562, 2013 | 54 | 2013 |
| Exploration of protein conformational change with PELE and meta-dynamics BP Cossins, A Hosseini, V Guallar Journal of Chemical Theory and Computation 8 (3), 959-965, 2012 | 46 | 2012 |
| Computational prediction of HIV-1 resistance to protease inhibitors A Hosseini, A Alibés, M Noguera-Julian, V Gil, R Paredes, R Soliva, ... Journal of Chemical Information and Modeling 56 (5), 915-923, 2016 | 24 | 2016 |
| Atomic picture of ligand migration in toluene 4-monooxygenase A Hosseini, M Brouk, MF Lucas, F Glaser, A Fishman, V Guallar The Journal of Physical Chemistry B 119 (3), 671-678, 2015 | 10 | 2015 |
| 990 Prodigiosin, a New Bcl-2 Homology Domain-3 Mimetic Proapoptotic Drug M Espona-Fiedler, V Soto-Cerrato, A Hosseini, V Guallar, R Perez-Tomas european journal of cancer, S239, 2012 | | 2012 |
